Tickr
Home Explore Daily Brief Market Watchlists Portfolio
Research
Catalysts Signal Factory Screener Market News Event Calendar Valuation Plot Heat Map Top Investors Industry Trends Options
AI Assistant Notifications Account
Summit Therapeutics Inc. logo

Summit Therapeutics Inc. (SMMT) Stock Ticker

NASDAQ: SMMT · Healthcare · Biotechnology
$15.48-4.70%
USD · as of 2026-09-28 · market cap $12.5B
Open SMMT in TickrDownload for iPhone

SMMT right now

Earnings in 20 days — the market expects a ±33% move.
bullishSqueeze primed: High short interest, slow to cover
Tickr signals on SMMT
Squeeze primedHigh short interest, slow to cover
Options expect by Oct 6±19.6%
Options expect by Oct 29±40.6%
Priced in for Oct 19 earnings±33.2%
IV rank (30-day)92% · rich
From Tickr's live models · 2026-09-29. Not investment advice.

Market factors today

Tickr 500 vs S&P 500+0.49%+1.0% MTD
Momentum L/S+1.35%+15.1% MTD
High-beta momo L/S+1.46%+22.2% MTD
Rate sensitivity L/S+1.91%+6.9% MTD
Oil sensitivity L/S-2.54%-5.3% MTD
Unprofitable tech-1.43%+3.7% MTD

Unlock the full SMMT picture

🔒 Implied move chart & probabilities
🔒 Live options flow
🔒 AI analysis & chat on SMMT
🔒 Catalysts & earnings
🔒 Strategy Lab
🔒 Financials & estimates
Start your 7-day free trial

About Summit Therapeutics Inc.

Summit Therapeutics Inc. is a biopharmaceutical firm dedicated to discovering, developing, and commercializing therapeutic solutions, primarily targeting infectious diseases across the United States and Latin America. The company's clinical development pipeline is heavily concentrated on therapies for Clostridioides difficile infection (CDI). Its flagship product candidate, ridinilazole, is an orally administered small molecule antibiotic currently advancing through Phase III clinical trials as a treatment for CDI. Beyond its lead asset, Summit Therapeutics is also progressing SMT-738, designed to combat multidrug-resistant infections, notably carbapenem-resistant Enterobacteriaceae (CRE). Additionally, its DDS-04 series represents a potential therapeutic avenue for various infections caused by the Enterobacteriaceae family of bacteria. Established in 2003, the company maintains its headquarters in Cambridge, Massachusetts.

SMMT stock facts

Ticker symbolSMMT
ExchangeNASDAQ Global Market
SectorHealthcare
IndustryBiotechnology
Market cap$12.5B
CEORobert W. Duggan
Employees265
HeadquartersMiami, FL, US
IPO date2015-03-05
Websitewww.smmttx.com

What you can see for SMMT on Tickr

Live SMMT price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the SMMT report.

Rankings

Largest Healthcare companiesLargest companies by market cap

FAQ

What is the ticker symbol for Summit Therapeutics Inc.?

The ticker symbol for Summit Therapeutics Inc. is SMMT, listed on the NASDAQ Global Market.

What is SMMT?

Summit Therapeutics Inc. is a biopharmaceutical firm dedicated to discovering, developing, and commercializing therapeutic solutions, primarily targeting infectious diseases across the United States and Latin America. The company's clinical development pipeline is heavily concentrated on therapies for Clostridioides difficile infection (CDI). Its flagship product candidate, ridinilazole, is an…

HomeExploreMarketLists
All pages